Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / IMRN - Australian biotech Immuron appoints CEO

IMRN - Australian biotech Immuron appoints CEO

Immuron Limited
Australia-based Immuron (NASDAQ:IMRN) appointed Steven Lydeamore as CEO, effective June 27. The company said Lydeamore recently served as CEO of Anatara Lifesciences. Immuron (IMRN) added that Jerry Kanellos, who has been interim CEO for the past two years will resume the role of COO following Lydeamore’s appointment. The company noted that pending Lydeamore starting his duties, Paul Brennan, non-executive director, will take on a consultancy role within the company with focus on an anticipated upcoming Travelan trials in the U.S. and interactions with the FDA.

For further details see:

Australian biotech Immuron appoints CEO
Stock Information
Company Name: Immuron Limited
Stock Symbol: IMRN
Market: NASDAQ
Website: immuron.com.au
Menu
IMRN IMRN Quote IMRN Short IMRN News IMRN Articles IMRN Message Board
Get IMRN Alerts

News, Short Squeeze, Breakout and More Instantly...